首页> 外文会议>International Molecular Medicine Tri-Conference. >Preservation of Circulating Tumor Cell RNA, Morphology, and Immunoreactivity Using a New Whole Blood Compatible Preservative
【24h】

Preservation of Circulating Tumor Cell RNA, Morphology, and Immunoreactivity Using a New Whole Blood Compatible Preservative

机译:使用新的全新血液相容防腐剂保存循环肿瘤细胞RNA,形态和免疫反应性

获取原文

摘要

BACKGROUND: Currently, circulating tumor cells (CTCs) can be isolated and enumerated for up to 96 hours following blood draw into a CellSave Preservative Tube. In CellSave, the CTCs are numerically and morphologically preserved, and their immunoreactivity remains sufficiently intact for immunologic enrichment; however RNA is rapidly degraded and lost from CTCs following exposure to CellSave. In general, most fixatives that could be used to collect and preserve blood samples are either incompatible with whole blood, bind up or degrade RNA, or lyse all the cells present. We report here on a new preservative that is compatible with whole blood and preserves CTC morphology and immunoreactivity while leaving the CTC RNA cell associated and intact. This preservative, called CellSecure, enables the enrichment of rare CTCs from blood in a way that facilitates their full immunochemical analysis or extraction of intact CTC RNA for whatever molecular analysis is desired. METHODS: Whole blood was collected in standard EDTA blood collection tubes, spiked with cell lines, and CellSecure was added. In control tubes, no CellSecure was added. Blood was tested either immediately after CellSecure addition or at 24 hour intervals up to 96 hours. Blood was processed using either the microfluidic Harpoon CTC Isolator and CTC Disk (Hrp-Isolator) technology, or using CELL SEARCH?. Cell lines were enriched from blood incubated from 0-96 hours in CellSecure and examined by flow cytometry to quantitate immunofluorescent reactivity of various antigens, immunofluorescently imaged and counted, or had RNA extracted. Extracted RNA was subjected to gel analysis to determine if it was intact or degraded, and probed for quantitative retention of CTC gene expression over time by qPCR. RESULTS: In CellSecure the white blood cell (WBC) antigen CD45 was stable or decreased in immunofluorescence intensity by ~10-40% over 96 hours, depending on the WBC type. Cell lines spiked into whole blood and stored up to 96 hours could be efficiently enriched and imaged from whole blood by either immunologic capture (CELLSEARCH?) or WBC negative depletion using the Hrp-Isolator microfluidic technologies. Morphology and immunoreactivity was preserved over time using CellSecure, although changes in the morphology of CTCs isolated using CELL SEARCH? were observed at 96 hours. Cells that were not preserved (EDTA alone) showed significant RNA degradation over time, and little or no intact RNA could be found when blood was stored in CellSave for 24 hours. In contrast, blood preserved using CellSecure showed intact RNA by gel analysis. qPCR analysis of RNA expressed by CTCs and WBCs showed expression levels at 96 hours that were either unchanged or only minimally different than the levels seen in the control tubes at time zero. CellSecure was found to work optimally with the Hrp-Isolator, up to 72 hours post draw, recovering between 90-100% of spiked cells with sufficient purity to enable direct qPCR analysis of CTC RNA expression levels. DISCUSSION: We have developed a preservative solution that is compatible with whole blood that preserves cells and the cellular antigens we have tested to date to a sufficient level for cell isolation and characterization; and importantly also preserves the RNA expressed by these cells. By keeping the RNA associated with the cell expressing it, we were able to enrich rare cell populations from 7.5 mLs of whole blood with sufficient purity to enable molecular analysis of genes expressed by these rare cell populations. RNA expression levels are stable for at least 96 hours post draw and 90-100% of the spiked rare cell populations could be recovered using the Hrp-Isolator technology for up to 72 hours post draw. This should enable CellSecure to be used in conjunction with the Hrp-Isolator for collection of samples and the subsequent immunological and molecular analysis of CTCs or other rare cell populations on shipped samples.
机译:背景:目前,循环肿瘤细胞(CTC)可以在血液绘制到细胞防腐剂管后至多96小时。在细胞中,CTC在数值上和形态保存,它们的免疫反应性仍然足够完整,可用于免疫富集;然而,在暴露于细胞后,RNA迅速降解并从CTCS中丢失。通常,可以用于收集和保护血液样品的大多数固定剂与全血,结合或降解RNA不相容,或粘合所有存在的细胞。我们在此报告新的防腐剂,其与全血相兼容,并保留CTC形态和免疫反应性,同时留下CTC RNA细胞相关和完整。这种被称为细胞的防腐剂使得能够以促进其全部免疫化学分析或提取完整的CTC RNA的方式来富集血液中的富含CTC,以便无论需要什么分子分析。方法:在标准EDTA血液收集管中收集全血,用细胞系掺入,并加入细胞。在对照管中,不加入细胞。在细胞中添加或在24小时间隔后立即测试血液,高达96小时。使用微流体鱼叉CTC隔离器和CTC盘(HRP隔离器)技术或使用细胞搜索处理血液处理血液。将细胞系从血液中富含0-96小时的细胞培养物中孵育并通过流式细胞术检查以定量各种抗原的免疫荧光反应性,免疫荧光成像和计数,或者提取RNA。对提取的RNA进行凝胶分析以确定是否完整或降解,并探讨通过QPCR过时定量保留CTC基因表达。结果:在细胞中,白色血细胞(WBC)抗原CD45在66小时内稳定或在免疫荧光强度稳定或减少,取决于WBC型。使用HRP隔离器微流体技术通过免疫捕获(Cellearch?)或WBC阴性耗尽,可以通过免疫捕获(Cellsearch?)或WBC阴性耗尽,从全血中掺入全血中并储存高达96小时的细胞系。使用细胞的时间随时间保存形态和免疫反应性,但使用细胞搜索分离的CTC的形态变化?在96小时内观察到。未保留的细胞(单独EDTA)显示出随时间的显着的RNA劣化,并且当血液中储存在细胞中时,可能会发现很少或没有完整的RNA。相反,使用细胞的血液通过凝胶分析显示完整的RNA。 CTCS和WBC表达的RNA的QPCR分析显示出96小时的表达水平,其不变,或者仅与在零时对照管中所见的水平微小不同。发现细胞沉淀物与HRP隔离器最佳地工作,后射回高达72小时,恢复90-100%的掺入细胞,具有足够的纯度,以实现CTC RNA表达水平的直接QPCR分析。讨论:我们开发了一种防腐剂解决方案,其与全血相容,这些血液保留细胞和细胞抗原,我们已经测试到细胞分离和表征的足够水平;并且,重要的是还保留了这些细胞表达的RNA。通过保持与表达细胞的细胞相关的RNA,我们能够通过足够纯度的7.5mL全血中富集稀有细胞群,以使这些稀有细胞群表达的基因分子分析。 RNA表达水平稳定至少96小时,并且可以使用HRP隔离器技术回收90-100%的掺入稀有细胞群,其抛光后最多72小时。这应该使细胞能够与HRP隔离器结合使用用于收集样品和随后的CTC或其他稀有细胞群的ICOP样品的免疫学和分子分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号